The Food and Drug Administration (FDA, USFDA) has given UC San Francisco the responsibility to investigate the effects of CBD (cannabidiol) as a drug for children with uncontrolled epileptic seizures. Participants in this study ranged in age from 1 year to 18 years. All of them suffered from similar symptoms, resistant to standard treatment.
Many of them suffer from Dravet syndrome (epilepsy with myoclonic-astatic seizures in infancy), which begins in early childhood and causes frequent seizures.
During the first months of using CBD, seizures decreased by 10%. The FDA says it will continue to work on this study.
Boy with autism speaks with CBD
At the age of 10 months, Puerto Rican Calela Santiago was diagnosed with a malignant tumor – neuroblastoma. Within 2 years, the boy passed the course…
New Gallup Poll: 14% of Americans Use CBD
It may have taken almost a century for the cannabis ban to be lifted, but it only took a few years for the world to fall in love with cannabidiol (CBD). Etc…
